R. Duke

发表

J. Cohen, R. Duke, K. Sellins, 1992, Nature.

D. Green, R. Schulte‐Hermann, D. McConkey, 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

A role for CD95 ligand in preventing graft rejection

D. Bellgrau, D. Gold, Jodene K Moore, 1995, Nature.

Human DU145 prostate cancer cells overexpressing mitogen-activated protein kinase phosphatase-1 are resistant to Fas ligand-induced mitochondrial perturbations and cellular apoptosis

A. Kraft, R. Duke, C. C. Franklin, 1999, Molecular and Cellular Biochemistry.

HIV gp120-specific cell-mediated immune responses in mice after oral immunization with recombinant Salmonella.

D. Looney, E. Ziegler, R. Duke, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Enhancing antimelanoma immune responses through apoptosis

G. Cutter, S. Fosmire, J. Modiano, 2003, Cancer Gene Therapy.

Self recognition by T cells. I. Bystander killing of target cells bearing syngeneic MHC antigens

R. Duke, Richard C. Duke, 1989, The Journal of experimental medicine.

Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity

D. Kuritzkes, D. Bellgrau, Cara C Wilson, 2001, Nature Medicine.

Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis.

T. Curiel, M. B. Purner, R. Duke, 1998, Journal of immunology.

Fas‐mediated apoptosis in seven human prostate cancer cell lines: Correlation with tumor stage

G. Miller, T. Hedlund, R. Duke, 1998, The Prostate.

DNA fragmentation in targets of CTL: an example of programmed cell death in the immune system.

L. Olson, J. Cohen, R. Chervenak, 1985, Advances in experimental medicine and biology.

Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells

G. Miller, A. Kraft, J. Schaack, 1999, Cell Death and Differentiation.

Apoptosis and programmed cell death in immunity.

V. Fadok, J. Cohen, R. Duke, 1992, Annual review of immunology.

Cytolysis mediated by ionophores and pore‐forming agents: role of intracellular calcium in apoptosis

D. Ojcius, Roxana Z. Witter, R. Duke, 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Purified perforin induces target cell lysis but not DNA fragmentation

J. D. Young, C. Liu, J. Cohen, 1989, The Journal of experimental medicine.

Cytotoxic lymphocyte-derived lytic granules do not induce DNA fragmentation in target cells.

J. Cohen, R. Duke, K. Sellins, 1988, Journal of immunology.

Differences in target cell DNA fragmentation induced by mouse cytotoxic T lymphocytes and natural killer cells.

J. Cohen, R. Chervenak, R. Duke, 1986, Journal of immunology.

A Mediator of Cytotoxic T Lymphocyte-Mediated Apoptosis and Immune Privilege

E. Newell, D. Bellgrau, Jodene K Moore, 1997 .

CD95 (Fas) Ligand

E. Newell, D. Bellgrau, Jodene K Moore, 1997 .

Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells.

J. Modiano, D. Bellgrau, R. Gianani, 2004, Clinical immunology.

Adenoviral-mediated gene transfer in lymphocytes.

S. Hunger, J. DeGregori, J. Schaack, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Apoptosis in cytotoxic T lymphocytes and their targets.

R. Duke, 1992, Seminars in immunology.

Methods of analyzing chromatin changes accompanying apoptosis of target cells in killer cell assays.

R. Duke, 2004, Methods in molecular biology.

Methods of analyzing chromatin changes accompanying apoptosis of target cells in killer cell assays.

R. Duke, 2000, Methods in molecular biology.

Co‐ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI‐231 cells from anti‐surface IgM‐induced apoptosis

V. M. Holers, Y. Kozono, R. Duke, 1995, European journal of immunology.

Endogenous endonuclease-induced DNA fragmentation: an early event in cell-mediated cytolysis.

J. Cohen, R. Chervenak, R. Duke, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Cell suicide in health and disease.

J. D. Young, D. Ojcius, R C Duke, 1996, Scientific American.

Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death.

J. Cohen, R. Duke, 1984, Journal of immunology.

Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells

J. Desbarats, M. Newell, R. Duke, 1998, Nature Medicine.

Tumorigenic human squamous lung cancer cells have defined cell surface carbohydrates that are absent from nontumorigenic cells.

D. Pettijohn, O. Pfenninger, J. Brown, 1988, Proceedings of the National Academy of Sciences of the United States of America.

IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells.

J. Cohen, R. Duke, 1986, Lymphokine research.

Mutation-specific control of BCR-ABL T315I positive leukemia with a recombinant yeast-based therapeutic vaccine in a murine model.

S. Dai, J. DeGregori, A. Franzusoff, 2010, Vaccine.

NF-κB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type

Y. Tao, R. Scheinman, R. Duke, 1999, Cell Death and Differentiation.

Human keratinocytes maintain reversible anti-apoptotic defenses in vivo and in vitro

M. Middleton, R. Duke, D. Norris, 2004, Apoptosis.

Mutation-Selective Tumor Remission with Ras-Targeted, Whole Yeast-Based Immunotherapy

L. Dwyer-Nield, A. Malkinson, D. Bellgrau, 2004, Cancer Research.

Inflammation, Apoptosis, and Necrosis Induced by Neoadjuvant Fas Ligand Gene Therapy Improves Survival of Dogs With Spontaneous Bone Cancer.

G. Cutter, V. Wilke, J. Modiano, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Naturally occurring translational models for development of cancer gene therapy

S. Fosmire, J. Modiano, D. Bellgrau, 2006 .

Immunologic cytotoxicity in alopecia areata: apoptosis of dermal papilla cells in alopecia areata.

M. Middleton, R. Duke, D. Norris, 1995, The Journal of investigative dermatology.

Reversible Resistance to Apoptosis in Cutaneous T Cell Lymphoma

R. Edelson, R. Duke, D. Norris, 2001, Annals of the New York Academy of Sciences.

Yeasts encoding tumour antigens in cancer immunotherapy

A. Franzusoff, R. Duke, T. King, 2005, Expert opinion on biological therapy.

Apoptosis and Cytotoxic T Lymphocytes

R. Duke, 1993 .

Regulation of Fas-mediated apoptosis by N-ras in melanoma.

R. Duke, D. Norris, Y. Shellman, 2002, The Journal of investigative dermatology.

Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins.

G. Lauer, D. Bellgrau, A. A. Haller, 2007, Vaccine.

T-Cell-Mediated Immunity and Immunotherapy of Chronic Hepatitis C

A. Franzusoff, R. Duke, D. Apelian, 2009 .

Isolation of the human PC6 gene encoding the putative host protease for HIV-1 gp160 processing in CD4+ T lymphocytes.

S. Pichuantes, L Miranda, J Wolf, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Macrophage colony-stimulating factor complementary DNA: a candidate for gene therapy in metastatic melanoma.

A. Dorner, R. Duke, P. Walsh, 1995, Journal of the National Cancer Institute.

Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis.

P. Schlievert, R. Duke, D. Leung, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Treatment of Ras mutation-bearing solid tumors using whole recombinant S. cerevisiae yeast expressing mutated Ras: Preliminary safety and immunogenicity results from a phase 1 trial

D. Bellgrau, M. Morse, S. Munson, 2005 .

Three‐dimensional spheroid cultures of human prostate cancer cell lines

G. Miller, T. Hedlund, R. Duke, 1999, The Prostate.

Proinflammatory consequences of transgenic fas ligand expression in the heart.

D. Nelson, S. Schwartz, D. Bellgrau, 2000, The Journal of clinical investigation.